Cross Country Healthcare (CCRN) EBIT (2016 - 2025)
Historic EBIT for Cross Country Healthcare (CCRN) over the last 17 years, with Q3 2025 value amounting to -$6.0 million.
- Cross Country Healthcare's EBIT fell 30935.86% to -$6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$16.2 million, marking a year-over-year decrease of 20292500.0%. This contributed to the annual value of -$16.9 million for FY2024, which is 11496.28% down from last year.
- Per Cross Country Healthcare's latest filing, its EBIT stood at -$6.0 million for Q3 2025, which was down 30935.86% from -$5.9 million recorded in Q2 2025.
- In the past 5 years, Cross Country Healthcare's EBIT registered a high of $90.6 million during Q1 2022, and its lowest value of -$19.2 million during Q2 2024.
- Moreover, its 5-year median value for EBIT was $20.3 million (2023), whereas its average is $25.9 million.
- As far as peak fluctuations go, Cross Country Healthcare's EBIT soared by 704146.98% in 2021, and later crashed by 30935.86% in 2025.
- Quarter analysis of 5 years shows Cross Country Healthcare's EBIT stood at $76.0 million in 2021, then crashed by 36.5% to $48.2 million in 2022, then crashed by 72.17% to $13.4 million in 2023, then plummeted by 125.57% to -$3.4 million in 2024, then tumbled by 73.99% to -$6.0 million in 2025.
- Its EBIT stands at -$6.0 million for Q3 2025, versus -$5.9 million for Q2 2025 and -$977000.0 for Q1 2025.